RE:RE:TimelineTrue. There could be a whole lot of very positive developments for shareholders before final approval, including the announcement of a jv, the granting of breakthrough designation, accelerated approval, priority review and the initiation of phase 1 trials for gbm and/or nsclc.
skys1 wrote: However, deals are often made before final approvals have been obtained. Especially when the treatment is in an area of substantial need like an effective NMIBC treatment with minor to no side effects, unlike the current treatments. .